Some studies suggest that GM–CSF inhibits tumor growth and metastasis (for example, in the case of colorectal cancer [53]), whereas other studies show that GM–CSF promotes tumor progression by supporting immunosuppressive TME and stimulating tumor growth and metastasis [54,55,56]. Here, CSF2 is linked to colorectal cancer.